Pro Medicus Limited (ASX: PME) has announced that it has won a $3 million contract extension with a German Government Hospital network.
Pro Medicus is a Melbourne-based software owner and developer, licensing products to large US hospitals and Australian radiology clinics. The company has offices in Richmond, Victoria, Berlin, Germany and in the United States.
Pro Medicus’ German Win
Pro Medicus announced this morning that a large German Government Hospital network has extended its use of Pro Medicus’ Visage 7 technology, which includes additional licences for the existing site and an additional two satellite hospitals.
For Pro Medicus, it will mean a capital sale with an upfront license value of more than $3 million. This project is based on a capital purchase model, the $3 million excludes ongoing service contracts.
Pro Medicus CEO Dr Sam Hupert spoke to the benefits of this contract saying, “This will provide us with our first large, multi-facility reference site in Europe which we see as instrumental to building the base for further sales in the region.”
The Visage 7 and Visage Open Archive software is planned to go live before the end of December 2018.
Visage Chief Technology Officer Dr Malte Westerhoff said: “Existing customers expanding their use of our offering is the best validation of the strength of our technology and of our customer service.”
The Pro Medicus share price is down 2%, likely due to the US market falling on Friday.
However, over the past year, Pro Medicus shares are up 26.6% and I think it could be one to watch as it grows its international earnings base. Some of the other small-cap ASX shares in our free report (see below) are also delivering rapid growth.
Here are 3 stocks I own in April 2020...
Amidst the COVID-19 confusion, there are some companies still growing FAST (think: online meetings through Zoom, streaming companies like Netflix and eHealth services provided by Teledoc).
While the world grapples with COVID-19, some companies are still growing rapidly. The entire cloud computing market is valued around $US210 billion but if you ask me, it seems clear as day that this market is only going to get bigger in 2020 and beyond.
That's why our top investment analyst has just identified 3 growth stocks in a net cash position, with strong competitive forces... and obvious tailwinds at their back. He owns all three of them right now!
Claim a FREE investing report on our analyst's "3 best share ideas for the cloud revolution" when you create a free Rask Australia account.
Our report is 100% free and unlocks hundreds of hours of bonus content.
Disclaimer and warning: The information on this website is general financial advice only. That means, the advice does not take into account your objectives, financial situation or needs. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. Please read our Terms of Service and Financial Services Guide before using this website.